Mainz BioMed N.V. | WebDisclosure

Basculer en Français

10613	Companies
225268	Keywords
153906	Articles
119183	Press releases

Home
Companies
Mainz BioMed N.V.

PRESS RELEASE

published on 07/25/2024 at 14:01, 1 year 10 months ago

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
Mainz Biomed launches enhanced ColoAlert test with new features to improve screening efficiency and user experience. The updates aim to optimize colorectal cancer detection

ColoAlert Mainz Biomed Colorectal Cancer Screening Efficiency Enhanced Test
BRIEF

published on 07/09/2024 at 09:06, 1 year 11 months ago

Mainz Biomed Submits for FDA Breakthrough Device Designation for CRC Screening Test

Mainz Biomed Colorectal Cancer FDA Submission Breakthrough Device Screening Test
BRIEF

published on 07/09/2024 at 09:06, 1 year 11 months ago

Mainz Biomed soumet une demande de désignation de dispositif révolutionnaire par la FDA pour le test de dépistage du CRC

Cancer Colorectal Mayence Biomed Soumission À La FDA Appareil Révolutionnaire Test De Dépistage
PRESS RELEASE

published on 07/09/2024 at 09:01, 1 year 11 months ago

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
Mainz Biomed N.V. seeks FDA Breakthrough Device Designation for Next Generation CRC Screening Test with impressive clinical results

Mainz Biomed N.V. Colorectal Cancer MRNA Biomarkers FDA Breakthrough Device Designation Next Generation CRC Screening Test
BRIEF

published on 07/02/2024 at 14:06, 1 year 11 months ago

Mainz Biomed Provides Half Year 2024 Corporate Update

Diagnostic Solutions FDA Approval Mainz Biomed Colorectal Cancer Half Year Results
BRIEF

published on 07/02/2024 at 14:06, 1 year 11 months ago

Mainz Biomed fournit une mise à jour d'entreprise pour le semestre 2024

Résultats Semestriels Cancer Colorectal Mayence Biomed Approbation De La FDA Solutions De Diagnostic
PRESS RELEASE

published on 07/02/2024 at 14:01, 1 year 11 months ago

Mainz Biomed Provides Half Year 2024 Corporate Update
Mainz Biomed N.V. provides corporate update for the first half of 2024, showcasing industry-leading clinical data and strategic partnerships. Expect half-year financial results in September 2024

Strategic Partnerships Corporate Update Clinical Data Mainz Biomed N.V. Half-year Financial Results
BRIEF

published on 06/03/2024 at 14:06, 2 years ago

Mainz Biomed Unveils Industry-Leading Study Results at ASCO 2024

Mainz Biomed MRNA Biomarkers ASCO 2024 CRC Detection Multimodal Screening
BRIEF

published on 06/03/2024 at 14:06, 2 years ago

Mainz Biomed dévoile les résultats d'une étude de pointe à l'ASCO 2024

Mayence Biomed Biomarqueurs D'ARNm ASCO 2024 Détection CRC Dépistage Multimodal
PRESS RELEASE

published on 06/03/2024 at 14:01, 2 years ago

Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
Mainz Biomed presented industry-leading results of its pooled study at ASCO 2024, demonstrating high sensitivity in detecting colorectal cancer and precancerous lesions using mRNA biomarkers and AI algorithm

Mainz Biomed Colorectal Cancer MRNA Biomarkers ASCO 2024 Precancerous Lesions

Accesswire

Published on 06/22/2026 at 15:58, 35 minutes ago

Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 1 hour 3 minutes ago

NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 1 hour 33 minutes ago

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 2 hours 32 minutes ago

Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 2 hours 33 minutes ago

Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 16:21, 11 minutes ago

Fuller, Smith & Turner PLC: Share Buyback Programme
Published on 06/22/2026 at 16:05, 28 minutes ago

ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
Published on 06/22/2026 at 15:33, 59 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/22/2026 at 15:32, 1 hour ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/22/2026 at 15:32, 1 hour 1 minute ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc

Les Echos

Published on 06/22/2026 at 14:42, 1 hour 50 minutes ago

COMMUNIQUE HOPENING 22 juin 2026
Published on 06/22/2026 at 08:30, 8 hours 3 minutes ago

Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 8 hours 3 minutes ago

Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 21 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 21 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026

View all LES ECHOS COMFI WIRE